Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Breast cancer poses a significant threat to women's health.
• The tumor microenvironment, including cell-to-cell interactions, critically influences cancer progression and metastasis.
• Small extracellular vesicles (sEVs) are key mediators of intercellular communication, carrying proteins, RNAs, and lipids.

Purpose of the Study:

• To review the regulatory mechanisms of tumor-derived sEVs in cancer development and progression.
• To explore the role of sEVs in proliferation, metastasis, drug resistance, and immunosuppression.
• To discuss the application of sEVs as cancer biomarkers and therapeutic targets.

Main Methods:

• Literature review of studies on small extracellular vesicles in breast cancer.
• Analysis of mechanisms by which sEVs influence cancer progression and metastasis.
• Examination of sEVs' potential in diagnostics and therapeutics.

Main Results:

• sEVs play a crucial role in cancer proliferation, invasion, and metastasis.
• Tumor-derived sEVs shape the premetastatic niche and influence metastatic organ tropism.
• sEVs contain oncogenic factors that mediate communication, impacting cancer progression.

Conclusions:

• sEVs are vital in mediating breast cancer progression and metastasis.
• Tumor-derived sEVs can serve as biomarkers for cancer progression and potential therapeutic targets.
• Engineering and clinical translation of sEVs offer promising avenues for cancer treatment and prevention.